MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q1
hinzugefügt 16.05.2026
Spectrum Pharmaceuticals Anteile 2011-2026 | SPPI
Anteile Jährlich Spectrum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 183 M | 155 M | 124 M | 111 M | 103 M | 85.1 M | 72.8 M | 64.9 M | 64.7 M | 60.7 M | 58.6 M | 53.3 M | 49.5 M | 39.3 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 183 M | 39.3 M | 87.5 M |
Anteile Vierteljährlich Spectrum Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 202 M | 203 M | 188 M | 176 M | 170 M | 165 M | 159 M | 155 M | 145 M | 146 M | 131 M | 113 M | 112 M | 113 M | 111 M | 110 M | 110 M | 111 M | 104 M | 103 M | 101 M | 101 M | 83.5 M | 78.6 M | 78.5 M | 80.5 M | 79.3 M | 68.6 M | 65.6 M | 68.2 M | 65.9 M | 65.5 M | 64.9 M | 66 M | 64.8 M | 64.6 M | 63.4 M | 64.1 M | 61.9 M | 59 M | 59.2 M | 60 M | 58.9 M | 58.8 M | 58.5 M | 59.2 M | 53.8 M | 52.3 M | 51.3 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 203 M | 51.3 M | 97.6 M |
Anteile anderer Aktien in der Pharmaeinzelhändler
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
38.7 M | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
4.73 M | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
10.2 M | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
220 M | - | - | $ 866 M | China |
 |
Deciphera Pharmaceuticals
DCPH
|
85.1 M | - | - | $ 2.18 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
44.7 B | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
543 M | - | -13.47 % | $ 169 M | France |
 |
Alpine Immune Sciences
ALPN
|
50 M | - | - | $ 2.17 B | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
192 M | - | -14.27 % | $ 1.7 M |  Singapore |
 |
AstraZeneca PLC
AZN
|
1.55 B | - | - | $ 96.9 B |  Britain |
 |
CureVac N.V.
CVAC
|
224 M | - | - | $ 867 M | Germany |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
4.28 M | - | - | $ 269 M | USA |
 |
Coherus BioSciences
CHRS
|
117 M | $ 1.38 | -2.82 % | $ 162 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
9.34 B | - | 0.74 % | $ 768 M |  Israel |
 |
Abcam plc
ABCM
|
229 M | - | - | $ 4.9 B | Britain |
 |
Galera Therapeutics
GRTX
|
98.5 M | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
54.9 B | - | -18.52 % | $ 27.3 M | Britain |
 |
Affimed N.V.
AFMD
|
120 M | - | -34.95 % | $ 21.5 M | Germany |
 |
CRISPR Therapeutics AG
CRSP
|
89.9 M | $ 49.99 | -2.89 % | $ 4.5 B |  Schweiz |
 |
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
21.6 M | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
22.6 M | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
68.9 M | - | -7.31 % | $ 87 M | USA |
 |
Celldex Therapeutics
CLDX
|
66.4 M | $ 29.54 | -0.2 % | $ 1.96 B | USA |
 |
Generation Bio Co.
GBIO
|
66.6 M | - | - | $ 344 M | USA |
 |
IMV
IMV
|
8.34 M | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M | Israel |
|
Enlivex Therapeutics Ltd.
ENLV
|
45.7 M | $ 0.7 | 1.33 % | $ 32 M | Israel |
 |
Esperion Therapeutics
ESPR
|
208 M | $ 3.15 | 0.32 % | $ 655 M | USA |
 |
Eton Pharmaceuticals
ETON
|
26.9 M | $ 31.07 | 1.77 % | $ 836 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
2.19 M | - | -4.36 % | $ 27 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
59.3 M | - | - | $ 384 M | Britain |
 |
Exelixis
EXEL
|
272 M | $ 53.14 | 0.27 % | $ 14.4 B | USA |
 |
Gracell Biotechnologies
GRCL
|
338 M | - | - | $ 3.37 B | China |
|
Forte Biosciences
FBRX
|
12.9 M | $ 16.84 | -0.94 % | $ 218 M | USA |
 |
Anika Therapeutics
ANIK
|
14.3 M | $ 14.71 | 0.96 % | $ 211 M | USA |
 |
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
3.17 M | - | 5.93 % | $ 314 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
14.3 M | - | 1.93 % | $ 17.4 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
1.65 M | $ 2.94 | 1.03 % | $ 4.84 M | Israel |
 |
Aptose Biosciences
APTO
|
2.45 M | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
67.7 M | - | -39.0 % | $ 4.57 M | USA |
 |
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | USA |